ダウンロード数: 221
タイトル: | Etretinateのヒト精子形成能におよぼす影響 |
その他のタイトル: | Effects of etretinate on spermatogenesis and endocrine parameter function in man |
著者: | 鈴木, 明 福谷, 恵子 簑和田, 滋 原, 慎 篠原, 充 岩動, 孝一郎 新島, 端夫 山田, 清 石橋, 康正 |
著者名の別形: | SUZUKI, Akira FUKUTANI, Keiko MINOWADA, Shigeru HARA, Makoto SHINOHARA, Mitsuru ISURUGI, Koichiro NIIJIMA, Tadao YAMADA, Kiyoshi ISHIBASHI, Yasumasa |
キーワード: | Etretinate Spermatogenesis Psoriasis |
発行日: | Jan-1986 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 32 |
号: | 1 |
開始ページ: | 55 |
終了ページ: | 59 |
抄録: | 治療量のetretinateは3ヵ月までの投与および観察では乾癬患者の造精機能に障害を与えない Nine adult men with psoriasis were treated orally with 50-75 mg/day aromatic retinoid, etretinate for more than 3 months. Semen analyses as well as measurement of serum levels of LH, FSH, prolactin, testosterone and estradiol were performed before and every month during the therapy for 3 months or more in order to study the effects of the drug on male reproductive function. Average sperm concentration at 2 months after the treatment by the drug was higher than the untreated value, although this was statistically not significant due to greater variations. Decrease in sperm count during the therapy was observed only in one patient. Sperm concentration of this case, however, was recovered and increased to higher levels after 6 months on the drug. No change was found in other semen parameters including sperm morphology. All hormone levels remained unchanged except for prolactin which increased. We conclude that etretinate did not cause suppression of spermatogenesis nor impairment of sperm motility or morphology as far as shown by the present observation periods. |
URI: | http://hdl.handle.net/2433/118721 |
PubMed ID: | 3083663 |
出現コレクション: | Vol.32 No.1 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。